Facing a New TrialSun & Moon · 2017Machamp-GX
TCGPlayer market
$33.51
- PSA 10
- $115.96
- PSA 9
- $22.35
Finish
Market prices
Ungraded prices from each marketplace we track, with sales activity where available.
TCGPlayer Market USD
$33.51
TCGPlayer Market
USD
—
eBay Average USD
$42.74
eBay Average
USD
—
eBay Sold USD
$42.12
eBay Sold
USD
—
Graded prices
Average sold price by grading company and grade.
- Grade 10
- $115.961 sold
- Grade 9
- $22.351 sold
| Grader | 10 | 9 |
|---|---|---|
| PSA | $1161 sold | $22.351 sold |
Price by condition
Ungraded market price for each printing, from Near Mint down to Damaged.
Holofoil
NM
Near Mint
$33.33
LP
Lightly Played
–
MP
Moderately Played
–
HP
Heavily Played
–
DM
Damaged
–
Got Machamp-GX? Scan the rest of your binder.
Point your camera at a card and PokiFrame identifies it and pulls live prices in about a second — free for iPhone and Android.
About Machamp-GX
Machamp-GX is a Japanese Pokémon card (#061) from Facing a New Trial, part of the Sun & Moon series, released in 2017.
An ungraded copy currently sells for about $33.51. A PSA 10 (Gem Mint) averages $115.96 — about 3.5× the raw price.
PokiFrame tracks Machamp-GX across TCGPlayer, Cardmarket and eBay sales so you can check its value before you buy, sell or trade.
Machamp-GX — common questions
- How much is Machamp-GX worth?
- Machamp-GX from Facing a New Trial has a market price of $33.51 for an ungraded copy, based on current TCGPlayer and eBay sales data. Condition, print variant and grading all move that number.
- What is a PSA 10 Machamp-GX worth?
- Recent PSA 10 (Gem Mint) sales of Machamp-GX averaged $115.96, about 3.5× the ungraded price. A PSA 9 averaged $22.35.
More from Facing a New Trial
All Facing a New Trial cards
Bellsprout
Facing a New Trial
Market
$4.71

Weepinbell
Facing a New Trial
Market
$4.02

Victreebel
Facing a New Trial
Market
$10.10

Ledyba
Facing a New Trial
Market
$0.89

Ledian
Facing a New Trial
Market
$0.97

Tapu Bulu
Facing a New Trial
Market
$1.01

Tapu Bulu-GX
Facing a New Trial
Market
$4.02

Salandit
Facing a New Trial
No recent price